Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Solid Biosciences (SLDB) FCF Margin (2021 - 2024)

Solid Biosciences (SLDB) has disclosed FCF Margin for 4 consecutive years, with 39478.67% as the latest value for Q4 2024.

  • Quarterly FCF Margin changed N/A to 39478.67% in Q4 2024 from the year-ago period, while the trailing twelve-month figure was 29415.29% through Dec 2024, down 4848223.0% year-over-year, with the annual reading at 77012.32% for FY2025, 10642761.0% down from the prior year.
  • FCF Margin hit 39478.67% in Q4 2024 for Solid Biosciences, up from 28931.71% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 39478.67% in Q4 2024 to a low of 1426.18% in Q1 2022.
  • Historically, FCF Margin has averaged 13954.26% across 4 years, with a median of 11640.02% in 2023.
  • Biggest five-year swings in FCF Margin: plummeted -78522bps in 2022 and later soared 2498073bps in 2023.
  • Year by year, FCF Margin stood at 537.12% in 2021, then skyrocketed by 49bps to 274.5% in 2022, then skyrocketed by 8681bps to 23554.55% in 2023, then skyrocketed by 68bps to 39478.67% in 2024.
  • Business Quant data shows FCF Margin for SLDB at 39478.67% in Q4 2024, 28931.71% in Q3 2024, and 24394.32% in Q2 2024.